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Abstract
Background: A prerequisite for safe cataract surgery is an adequately dilated pupil. The authors
conducted a trial to assess the efficacy (in terms of pupil diameter) of a depot method of pre-
operative pupil dilatation, as compared with repeated instillations of drops (which is time-
consuming for the nursing staff and uncomfortable for the patient).
Methods: A prospective randomised masked trial was conducted comprising 130 patients with no
significant ocular history undergoing elective clear corneal phacoemulsification. 65 patients had
mydriatic drops (Tropicamide 1%, Phenylephrine 2.5%, Diclofenac sodium 0.1%) instilled prior to
surgery, 65 had a wick soaked in the same drop mixture placed in the inferior fornix. Horizontal
pupil diameters were recorded on a millimetre scale immediately prior to surgery.
Results: There was no significant difference in pupil size between the two groups (p = 0.255,
Student's t-test).
Conclusion: There was no significant difference between the mydriasis obtained with the depot
system compared with conventional drop application. Use of a depot mydriatic delivery system
appears to be a safe and efficient method of drug delivery.
Trial Registration: International Standard Randomised Controlled Trial Number Register
ISRCTN78047760.
Background
A prerequisite for safe cataract surgery is an adequately
dilated pupil. Various methods of mydriatic drug delivery
have been studied, including sprays and depots, with the
common goal of obtaining maximal dilatation of the
pupil efficiently and comfortably [1-3]. Some studies have
also looked at combining the dilating agents into single
preparations for ease of use [1,3-5].
A previous study of corneal anaesthesia produced by
depot drug application showed that this produced longer
corneal anaesthesia compared with drops, despite there
being a smaller drug concentration overall [5]. This
increased 'bioavailability' is the common principle
behind all forms of depot mydriatic delivery, and formed
the basis for our study.
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BMC Ophthalmology 2006, 6:36 http://www.biomedcentral.com/1471-2415/6/36A recent uncontrolled study [6] showed that a change in
practice to using a pre-soaked wick had acceptable results
with respect to pupil dilatation. Our study was carried out
in a controlled, prospective, randomised, and masked
fashion in an attempt to provide sound evidence of this
suggested effect.
Methods
Ethics committee approval was obtained prior to com-
mencement of the study. Patients who were scheduled for
routine cataract surgery were selected for participation in
the study. Exclusion criteria were a history of diabetes,
uveitis, any pupillary abnormalities, pseudoexfoliation,
use of miotics (but not other glaucoma medications), and
very dark irides; all of these might prevent reliable assess-
ment of pupillary dilatation with the naked eye or may be
a cause for inadequate/irregular pupil dilatation.
Fully informed patient consent was obtained prior to par-
ticipation. 130 patients were enrolled into the study, each
of whom was about to undergo unilateral cataract extrac-
tion via small incision clear corneal phacoemulsification.
This number was obtained from a power calculation,
looking for a medium effect size (0.5), with p = 0.05, aim-
ing for α = 0.8, allowing for a drop-out rate. Patients were
randomised into two groups of 65 cases, and 65 controls.
An envelope was opened if the patient signed the consent
form, which contained either the word WICK (for the
cases), or DROPS (for the controls), and the patient was
assigned to their respective group.
The DROPS group received a statim dose of Diclofenac
sodium 0.1%, and then alternate Tropicamide 1% and
Phenylephrine 2.5% at 15-minute intervals in the pre-
operative hour (i.e. four of each irrespective of observed
pupil size). This is the local standard practice.
The WICK group received a statim dose of proparacaine
followed by insertion of a mydriatic-soaked wick (BD
visidrain™ eye fluid wick, cut into 1 cm strips) into the
lower fornix. The wick used in the WICK group had been
soaked in an equal part mixture of the above drops. No
further topical medications were applied to the WICK
group, and it was ensured at the time of placement that
the wick was completely obscured from view.
In the local Eye Unit, patients for cataract surgery all arrive
at the same time, 1.0 hours prior to start time. All the
patients receive dilating drops (or wicks) at the same time.
Their subsequent pupil measurements occur between 1.0
and 4.0 hours from instigation of mydriasis. Upon arrival
in the anaesthetic room, all patients had measurement of
horizontal pupil diameter with a pair of callipers to within
half a millimetre by a masked observer (who was the doc-
tor administering the local anaesthetic). The same calli-
pers were used throughout the study period. Callipers are
precision instruments, easily obtainable and easy to use,
which is why this method was used for assessment of
pupil diameter. Subsequently, the doctor checked for the
presence or absence of a wick in the inferior fornix and
removed it with forceps if in situ. Pupil diameter and pres-
ence/absence of a wick were both recorded on the data
sheet. Data on intra-operative and post-operative pupil
diameters were not collected.
Results
There was no significant difference between the observed
pupil sizes in the two groups of patients (Student's t-test:
p = 0.255, Table 1 & Figure 1).
One wick was inadvertently left in situ by the doctor
administering the local anaesthetic, and was subsequently
removed by the surgeon in the operating theatre. Having
been wrongly noted to have 'no wick' in situ, this was sub-
sequently corrected.
No adverse events were experienced in either group, and
surgery was uncomplicated in all cases. Importantly, there
were no adverse incidents secondary to inadequate pupil
dilatation in either group. No patient was unable to toler-
ate the wick. One wick fell out shortly after insertion, so
that patient was excluded from the study. A small dropout
rate occurred secondary to improper or incomplete filling
in of forms, hence there are not 65 responders in each
group, as shown by 'n' in the tables.
Discussion
In this single-masked, randomised controlled trial we
have demonstrated that pupil dilatation using a depot
method of mydriatic drug delivery is no different to the
local practice in achieving a pre-operative pupil diameter
which allowed safe cataract surgery during the study
period.
Table 1: Pupil diameters (mm)
Mean Median Standard Deviation No. of Patients (n)
Wicks 8.198 8 1.213 53
Drops 7.968 8 0.877 57
Statistical value p = 0.255Page 2 of 4
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BMC Ophthalmology 2006, 6:36 http://www.biomedcentral.com/1471-2415/6/36Previous studies [1-3] have examined novel ways of
administering mydriatics prior to cataract surgery. Siderov
et al [7] showed a small, statistically significant, but not
clinically significant difference in pupil sizes when sub-
jects received tropicamide alone, compared with tropica-
mide following administration of proparacaine (in favour
of the proparacaine group). This was only true for patients
with light-coloured irides. Mechanisms suggested for this
difference were disruption of the corneal epithelium, and
reduced reflex tearing through increased comfort. How-
ever, Siderov et al found only a paucity of data supporting
the use of proparacaine in conjunction with tropicamide
alone. There is significant data supporting the facilitation
which proparacaine offers in the pupillary dilatation with
phenylephrine. [8-10] These factors would have resulted
in increased bioavailability in our study, however we were
unable to demonstrate any such effect in our WICK group.
There was a large variability in the delay between instiga-
tion of mydriasis and measurement of pupil diameters.
This is due to the logistical nature of running a busy cata-
ract day surgery unit in a District General Hospital in the
UK. However, given that patients in both groups were
exposed to this random variability, and given the substan-
tial numbers of participants in each group, then the effect
of this confounding factor would be greatly reduced.
Apt and Henrick did find a consistent and statistically sig-
nificant increase in pupil sizes [5] depending on whether
proparacaine was used prior to instillation of various
mydriatic preparations. Our WICK group may or may not
therefore have had an enhanced mydriatic effect following
the prior administration of proparacaine, meaning that
without proparacaine the WICK method may not actually
be as effective as standard drop instillation as described
above.
Ong-Tone showed that satisfactory pupillary dilatation
was achieved when mydriatic-soaked wicks were used to
dilate pupils pre-operatively, as compared with standard
drop instillation [6]. The main outcome measure was that
pupils were noted to be adequately or inadequately
dilated. The study found no statistical difference between
the two groups. There was no mention of blinding or ran-
domisation, nor were there any numerical data on the
sizes of the pupils achieved with either method. There was
also no definition of what constituted an adequately or
inadequately dilated pupil. Consequently, we found it dif-
ficult to draw sound conclusions from this study. We
deliberately designed our study to be conducted in a pro-
spective, randomised, single-blind case-controlled man-
ner, in order to exclude bias.
Graph of study results. Pupil diametersFigure 1
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There is also the unmeasured effect on nursing resource
and the economics of surgery. We noted anecdotally dur-
ing the study period that the nursing staff found applica-
tion of the wick a simple, efficient, one-off event, and it
freed them up for other duties. Based on the costs of the
drops and other materials used at the time of the study, we
calculated a saving of approximately three pounds sterling
per session, based on five cataract patients per list. When
applied to the significant volume of cataract surgery car-
ried out in Europe and abroad, this represents a not incon-
siderable saving.
Conclusion
Use of a wick pre-soaked in standard mydriatic and non-
steroidal anti-inflammatory drugs appears to be a safe and
effective method of pupillary dilatation prior to routine
cataract surgery which is well tolerated by patients in the
presence of proparacaine. Additional benefits may
include a saving both in financial terms and in the nursing
resource required in a busy cataract unit.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
VD designed the study, wrote the protocols, helped recruit
the patients, and wrote the paper.
NW helped recruit the patients, performed statistical anal-
ysis, and co-wrote the paper.
ML and SM assisted in study design, and helped recruit the
patients.
JL oversaw the trial and gave final approval for the manu-
script.
All authors read and approved the final manuscript.
References
1. Patel CK, Bui TA, Gregariou G: A peroperative mydriatic
regime using a single application of tropicamide Novel Oph-
thalmic Delivery system & Gutt. Phenylephrine 10%.  Eye
1995, 9(Pt 3):337-40.
2. Akman A, Aydin P: A comparison of mydriatic efficacy of spray
application and drop instillation of tropicamide 1%.  Eye 1999,
13(Pt 5):653-5.
3. Lawrenson JG, Edgar DF, Cudgeon AC, Burns JM, Geraint M, Barnard
NAS: A comparison of the efficacy and duration of action of
topically applied proxymetacaine using a novel ophthalmic
delivery system versus eye drops in healthy young volun-
teers.  Br J Ophthalmology 1993, 77:713-715.
4. Tokuda K, Hirowatari T, Kamei Y, Mizayaki Y, Matsubara M: TPD
Ophthalmic solution (a mixture of tropicamide, phenyle-
phrine hydrochloride, and diclofenac sodium) for cataract
surgery.  Nippon Ganka Gakkai Zasshi 2002, 106(10):630-5.
5. Apt L, Henrick A: Pupillary dilatation with single eye drop
mydriatic combinations.  Am J Ophthalmology 1980, 89:553-559.
6. Ong-Tone L: Use of a wick to deliver preoperative mydriatics
for cataract surgery.  J Cataract Refract Surg 2003, 29:2060-2062.
7. Siderov J, Chuang SM, Ian K, Prassinos G, Tziortzi E, Wong JY: Effect
of proparacaine on tropicamide-induced mydriasis.  Optom Vis
Sci 1997, 74(12):1039-43.
8. Jauregui MJ, Polse KA: Mydriatic effect using phenylephrine and
proparacaine.  Am J Optom Physiol Opt 1974, 51:545-9.
9. Kubo DJ, Wing TW, Polse KA, Jauregui MJ: Mydriatic effects using
low concentrations of phenylephrine hydrochloride.  J Am
Optom Assoc 1975, 46:817-22.
10. Lyle WM, Bobier WR: Effects of topical anaesthesia on phenyle-
phrine-induced mydriasis.  Am J Optom Physiol Opt 1977,
54:276-81.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2415/6/36/prepubPage 4 of 4
(page number not for citation purposes)
